Profile
STVN ISRG BDX BDXA ALC RMD
Company Name Stevanato Group S.p.A. Intuitive Surgical, Inc. Becton, Dickinson and Company Becton, Dickinson and Company Alcon Inc. ResMed Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $4.23B $173.36B $59.94B $55.91B $39.26B $37.85B
Employees 5.52K 15.64K 70.00K 0.00K 25.60K 9.98K
CEO Franco Stevanato David J. Rosa Thomas E. Polen Jr. - David J. Endicott Michael J. Farrell
Ratings
STVN ISRG BDX BDXA ALC RMD
Quant Rating Score 2 1 3 5 3 4
Quant Rating Sell Strong Sell Neutral Strong Buy Neutral Buy
Trading
STVN ISRG BDX BDXA ALC RMD
Last Close $21.51 $546.71 $190.98 $59.24 $76.61 $244.71
High 52 $27.95 $610.45 $249.08 $59.24 $98.3 $293.73
Low 52 $17.85 $429.59 $165.15 $59.24 $72.05 $204.58
Price vs. 52 Week High -23.04 % -10.44 % -23.33 % 0 % -22.07 % -16.69 %
Price vs. 52 Week Low 20.5 % 27.26 % 15.64 % 0 % 6.33 % 19.62 %
Total Return
STVN ISRG BDX BDXA ALC RMD
1 Month Return -11.99 % 22.54 % 0.99 % 0 % 2 % -8.72 %
3 Month Return -4.78 % 13.64 % -2.06 % 0 % -13.07 % -14.47 %
6 Month Return -10.45 % -3 % 8.88 % 0 % -14.72 % -2.77 %
9 Month Return 7.12 % -9.02 % -15.17 % 0 % -14.35 % 6.13 %
YTD Return -1.28 % 4.74 % -15.82 % 0 % -9.75 % 7.01 %
1 Year Return 18.51 % 1.46 % -14.22 % 0 % -10.32 % 2.77 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
STVN ISRG BDX BDXA ALC RMD
Dividend Yield Percentage (TTM) 0.39 % - 1.99 % 2.18 % 0.42 % 0.87 %
Dividend Paid and Capex Coverage Ration (TTM) 0.87 % 4.3 % 1.75 % 1.74 % 3.02 % 4.31 %
Dividend Per Share (TTM) 0.05 % - 4.17 % 3.95 % 0.33 % 2.26 %
Payout Ratio (TTM) - - 71.28 % 67.9 % 15.49 % 22.31 %
Growth
STVN ISRG BDX BDXA ALC RMD
Asset Growth 12.42 % - 18.95 %
Gross Profit Growth -11.05 % 18.13 % 15.05 %
Revenue Growth 1.72 % 20.51 % 9.84 %
Revenue 3 Year 26.91 % 61.21 % 43.19 %
Revenue 5 Year 99.61 % 127.11 % 71.22 %
Revenue 10 Year - 294.9 % 193.47 %
EBIT Growth -13.78 % 40.98 % 28.01 %
Net Income Growth -19.13 % 22.97 % 37.2 %
Net Income 3 Yeari Growth Per Share -14.94 % 115.26 % 78.91 %
Net Income 5 Yeari Growth Per Share 191.45 % 164.83 % 121.66 %
Net Income 10 Yeari Growth Per Share - 353.8 % 280.03 %
Operating Income Growth -19.72 % 25.4 % 27.69 %
Operating Cash Flow Growth (CFG) 48.06 % - 25 %
Operating 3 Year CFG 13.33 % -100 % 396.61 %
Operating 5 Year CFG 254.96 % -100 % 114.79 %
Operating 10 Year CFG - -100 % 337.65 %
EPS Growth -21.82 % 22.32 % 37.61 %
EPS Diluted Growth -21.82 % 22.59 % 37.43 %
Book Value Per Share 20.39 % -100 % 22.95 %
Share Holder 3 Year Equity Growth Per Share 61.78 % -100 % 76.79 %
Share Holder 5 Year Equity Growth Per Share 413.12 % -100 % 135.12 %
Share Holder 10 Year Equity Growth Per Share - -100 % 259.96 %
Dividend Per Share Growth -1.79 % - 10.35 %
Dividend 3 Year Growth Per Share 25.22 % - 26.15 %
Dividend 5 Year Growth Per Share 127.3 % - 35.87 %
Dividend 10 Year Growth Per Share - - 89.26 %
Debt Growth 8.16 % - -2.53 %
Free Cash Flow Growth 53.14 % - 29.18 %
Updated On 31 Dec 2024 31 Dec 2025 30 Jun 2025
Profitability
STVN ISRG BDX BDXA ALC RMD
Gross Profit Margin TTM 28.63 % 66.06 % 45.44 % 45.76 % 55.12 % 60.08 %
Return on Assets TTM 5.82 % 14.76 % 3.03 % 3.2 % 3.32 % 17.31 %
Return on Equity TTM 9.94 % 16.72 % 6.63 % 6.38 % 4.77 % 25.13 %
Return on Capital Employed TTM 10.05 % 16.78 % 5.48 % 5.06 % 5.06 % 24.74 %
Net Income Per EBT TTM 74.79 % 86.25 % 89.16 % 85.17 % 84.1 % 82.6 %
EBT Per Ebit TTM 96.12 % 112.42 % 73 % 75.87 % 86.34 % 99.79 %
EBIT Per Revenue TTM 16.71 % 29.27 % 11.8 % 12.4 % 14.16 % 33.18 %
Cash Flow To Debt Ratio TTM 52.32 % - 17.88 % 18.87 % 39.18 % 222.53 %
Receivables Turnover TTM 2.39 7.27 7.29 8.74 5.26 5.49
Payables Turnover TTM 3.97 11.73 - - 5.11 7.87
Inventory Turnover TTM 3.04 1.92 3.06 2.91 1.88 2.22
Fixed Asset Turnover TTM 87.99 % 195.4 % 312.12 % 314.44 % 198.09 % 724.52 %
Asset Turnover TTM 48.48 % 52.01 % 39.47 % 39.98 % 32.34 % 63.28 %
Operating Cash Flow Per Share TTM 0.85 8.34 11.97 11.91 4.16 12.86
Free Cash Flow Per Share TTM -0.12 6.4 9.32 9.23 3.11 12.06
Cash Per Share TTM 40.8 % 1383.15 % 299.71 % 263.44 % 303.41 % 944.79 %
Operating Cash Flow Sales Ratio TTM 20.13 % 29.42 % 15.71 % 15.48 % 20.13 % 35.82 %
Free Cash Flow Operating Cash Flow Ratio TTM -14.31 % 76.72 % 77.84 % 77.52 % 74.75 % 93.83 %
Cash Flow Coverage Ratios TTM 52.32 % - 17.88 % 18.87 % 39.18 % 222.53 %
Price To Free Cash Flows Ratio TTM -105.75 76.32 22.45 19.55 25.61 21.42
Price To Operating Cash Flows Ratio TTM 15.4 58.52 17.55 15.17 19.09 20.16
Price Cash Flow Ratio TTM 15.4 58.52 17.55 15.17 19.09 20.16
Income Statement (TTM)
STVN ISRG BDX BDXA ALC RMD
Revenue $1.1B $10.06B $21.84B $21.84B $9.91B $5.15B
Gross Profit $0.3B $6.64B $9.92B $9.92B $5.51B $3.05B
Gross Profit Ratio 27.38% 66% 45.44% 45.44% 55.61% 59.36%
EBITDA $0.25B $3.62B $4.96B $4.96B $2.68B $1.91B
Net Income $0.12B $2.86B $1.68B $1.68B $1.02B $1.4B
EPS Diluted 0.43 7.87 5.83 5.83 2.05 9.51
Balance Sheet (MRQ)
STVN ISRG BDX BDXA ALC RMD
Long Term Debt $0.32B $0.26B $17.62B $17.62B $4.97B $0.81B
Total Liabilities $0.92B $2.69B $29.94B $29.94B $8.79B $2.21B
Total Equity $1.4B $17.94B $25.39B $25.39B $21.55B $5.97B
Total Investments $0.01B $5.87B $0.01B $0.01B $0.91B $0.09B
Total Debt $0.43B $0.3B $19.18B $19.18B $5.14B $0.85B
Total Assets $2.33B $20.63B $55.33B $55.33B $30.35B $8.17B
Cash Flow Statement (TTM)
STVN ISRG BDX BDXA ALC RMD
Net Income $0.16B $2.88B $1.68B $1.68B $1.02B $1.4B
Inventory $0.01B $-1.06B $-0.41B $-0.41B $-0.05B $-0.08B
Dividends Paid $-0.01B $0B $-1.2B $-1.2B $-0.13B $-0.31B
Operating Cash Flow $0.16B $3.03B $3.43B $3.43B $2.08B $1.75B
Capital Expenditure $-0.31B $-0.54B $-0.76B $-0.76B $-0.67B $-0.09B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 1.29
ALC Alcon Inc. 79.39
ANGO AngioDynamics, Inc. 11.37
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 140.01
ATRC AtriCure, Inc. 32.895
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 0.474
AVTR Avantor, Inc. 9.64
AZTA Azenta, Inc. 30.45
BAX Baxter International Inc. 22.27
BDX Becton, Dickinson and Company 180.62
BDXA Becton, Dickinson and Company 59.24
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 17.03
BLFS BioLife Solutions, Inc. 22.25
COO The Cooper Companies, Inc. 83.05
DXR Daxor Corporation 12.5909
EKSO Ekso Bionics Holdings, Inc. 9.91
ETFs With Exposure to STVN
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.07 172.7
FPXI First Trust International Equity Opportunities ETF 0.58 67.585
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.000001 33.151
VINEX Vanguard International Explorer Fund Investor Shares 0.08 22.17
KOMP SPDR S&P Kensho New Economies Composite ETF 0.057704 62.83
BOUT Innovator IBD Breakout Opportunities ETF 2.98 40.37
BKIE BNY Mellon International Equity ETF 0 100.9
GSID Goldman Sachs MarketBeta International Equity ETF 0 75.24
GSUS Goldman Sachs MarketBeta US Equity ETF 0 95.32
VGHAX Vanguard Health Care Fund Admiral Shares 0.06 87.3
VGHCX Vanguard Health Care Fund Investor Shares 0.06 207.06
SENT AdvisorShares Alpha DNA Equity Sentiment ETF 1 21.2172
IGDA.L Invesco Markets II plc - Invesco Dow Jones Islamic Global Developed Markets UCITS ETF 0.0013 35.7975
LETB AdvisorShares Let Bob AI Powered Momentum ETF 1.25 22.835
GDOC Goldman Sachs Future Health Care Equity ETF 0 34.3
VEXPX Vanguard Explorer Fd 0.02903 120.98
VEXRX Vanguard Explorer Fund 0.02903 112.44
GXUS Goldman Sachs ETF Trust II - Goldman Sachs MarketBeta Total International Equity ETF 0 61.285
NBSM Neuberger Berman Small-Mid Cap ETF 1.36 27.36
Unlock